Your path to business agility
Dr. Sonnenblick, Planview’s Chief Data Scientist, holds years of experience working with some of the largest pharmaceutical and life sciences companies in the world. Through this in-depth study and application, he has successfully formulated insightful prioritization and portfolio review processes, scoring systems, and financial valuation and forecasting methods for enhancing both product forecasting and portfolio analysis. Dr. Sonnenblick holds a Ph.D. and MS from Carnegie Mellon University in Engineering and Public Policy and a BA in Physics from the University of California, Santa Cruz.
I recently read The Black Swan by Nassim Nicholas Taleb and found the book’s central tenets relevant to R&D portfolio management. I recommend you pick up a copy yourself, but until you do, I hope the following thoughts hit the mark for you as they did for me. What is a “Black Swan?” According to...
